Agile Therapeutics | AGRX - Операционный доход



Операционный доход Изменить Дата
Adma Biologics USD 50.29M 12.46M 2026-03
Alterity Therapeutics Limited AUD -8.07M 302.4K 2025-12
Bayer EUR 3.53B 2.42B 2026-03
BioMarin Pharmaceutical USD 129.65M 68.74M 2026-03
Cassava Sciences USD -11.17M 2.38M 2026-03
Cipla INR 8.88B 2.74B 2026-06
Clal Biotechnology ILS -1.74M 7.46M 2022-12
Compugen USD -9.02M 65.06M 2026-03
CSL USD 2.64B 1.97B 2025-12
Grifols EUR 320.55M 91.01M 2025-12
J&J USD 7.48B 860M 2026-06
Merck USD -1.88B 8.12B 2026-03
Pacira USD 4.62M 1.43M 2026-03
Pfizer USD 4.99B 340M 2026-03
TherapeuticsMD USD -1.18M 40K 2024-06